{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:58:11Z","timestamp":1760043491224,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.ahj.2004.04.034","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T00:02:41Z","timestamp":1103155361000},"page":"1028-1033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["How does the prognosis of diabetes compare with that of established vascular disease? Insights from the Canadian Vascular Protection (VP) Registry"],"prefix":"10.1016","volume":"148","author":[{"given":"Daniel G.","family":"Hackam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary K.K.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George N.","family":"Honos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence A.","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoly","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun G.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2004.04.034_BIB1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/01.CIR.0000089189.70578.E2","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II","volume":"108","author":"Luscher","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.04.034_BIB2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archneur.1996.00550070041010","article-title":"Traditional risk factors and ischemic stroke in young adults: the Baltimore-Washington Cooperative Young Stroke Study","volume":"53","author":"Rohr","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ahj.2004.04.034_BIB3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.04.034_BIB4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2004.04.034_BIB5","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2004.04.034_BIB6","doi-asserted-by":"crossref","unstructured":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ 2002;324:71\u201386","DOI":"10.1136\/bmj.324.7329.71"},{"key":"10.1016\/j.ahj.2004.04.034_BIB7","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0735-1097(03)00262-6","article-title":"Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials","volume":"41","author":"Shekelle","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2004.04.034_BIB8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"10.1016\/j.ahj.2004.04.034_BIB9","first-page":"S58","article-title":"Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"27","year":"2003","journal-title":"Canadian J Diabetes"},{"key":"10.1016\/j.ahj.2004.04.034_BIB10","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.2337\/diacare.27.2007.S15","article-title":"Standards of Medical Care in Diabetes","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2004.04.034_BIB11","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2337\/diacare.21.9.1432","article-title":"Population-based assessment of the level of care among adults with diabetes in the U.S","volume":"21","author":"Beckles","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2004.04.034_BIB12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00007","article-title":"Medical care for patients with diabetes. Epidemiologic aspects","volume":"124","author":"Harris","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2004.04.034_BIB13","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jama.281.14.1291","article-title":"Diabetes and decline in heart disease mortality in US adults","volume":"281","author":"Gu","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2004.04.034_BIB14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.04.034_BIB15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.7326\/0003-4819-139-10-200311180-00010","article-title":"Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management","volume":"139","author":"Hurst","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2004.04.034_BIB16","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1161\/01.CIR.101.17.2040","article-title":"Type II diabetes abrogates sex differences in endothelial function in premenopausal women","volume":"101","author":"Steinberg","year":"2000","journal-title":"Circulation"},{"year":"1998","series-title":"Williams Textbook of Endocrinology","key":"10.1016\/j.ahj.2004.04.034_BIB17"},{"key":"10.1016\/j.ahj.2004.04.034_BIB18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1592\/phco.23.1.73.31923","article-title":"Improving aspirin prophylaxis in a primary care diabetic population","volume":"23","author":"Faragon","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ahj.2004.04.034_BIB19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0002-9149(00)01447-8","article-title":"Lipid management among coronary artery disease patients with diabetes mellitus or advanced age","volume":"87","author":"Massing","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2004.04.034_BIB20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1365-2710.1998.00138.x","article-title":"Evaluation of drug usage and expenditure in a hospital diabetes clinic","volume":"23","author":"Wu","year":"1998","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ahj.2004.04.034_BIB21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1445-5994.1998.tb01958.x","article-title":"Management of patients with diabetes after heart attack: a population-based study of 1982 patients from a heart disease register","volume":"28","author":"Lim","year":"1998","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.ahj.2004.04.034_BIB22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0895-4356(99)00055-4","article-title":"Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus","volume":"52","author":"Glynn","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ahj.2004.04.034_BIB23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/106002809603000304","article-title":"Use of antidiabetic and antihypertensive drugs in hospital and outpatient settings in Hong Kong","volume":"30","author":"Lau","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ahj.2004.04.034_BIB24","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0195-668X(02)00828-X","article-title":"Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction","volume":"24","author":"Norhammar","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2004.04.034_BIB25","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2337\/diacare.26.5.1427","article-title":"Processes and outcomes of care for diabetic acute myocardial infarction patients in Ontario: do physicians undertreat?","volume":"26","author":"Alter","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2004.04.034_BIB26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s002280050285","article-title":"Drug prescription in diabetic patients in Stockholm in 1992 and 1995\u2013change over time","volume":"52","author":"Wandell","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2004.04.034_BIB27","first-page":"333","article-title":"Treatment of hypertension in patients with comorbidities: results from the study of hypertensive prescribing practices (SHyPP)","volume":"12","author":"Mehta","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ahj.2004.04.034_BIB28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0735-1097(98)00225-3","article-title":"Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2","volume":"32","author":"Barron","year":"1998","journal-title":"J Am Coll Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304002583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304002583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:11:48Z","timestamp":1757567508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870304002583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0002870304002583"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2004.04.034","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How does the prognosis of diabetes compare with that of established vascular disease? Insights from the Canadian Vascular Protection (VP) Registry","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2004.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}